Login / Signup

Safety Profile of Niraparib as Maintenance Therapy for Ovarian Cancer: A Systematic Review and Meta-Analysis.

Antonia PagkaliIoannis MamaisAdamantios MichalinosAris P Agouridis
Published in: Current oncology (Toronto, Ont.) (2022)
Niraparib is considered an effective and well-tolerated choice, with an improved safety profile, for the maintenance treatment of EOC patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • decision making
  • patient reported